What's breaking now, across thousands of outlets.
Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
You could be breeding potentially dangerous mosquitoes in your own garden without even realising it. A dog’s water bowl, a […]
(MedPage Today) -- Congo's Ebola outbreak has killed more than 3,000 people out of over 6,100 confirmed cases, the latest government data showed Wednesday, as the disease is spreading at an…
A popular sugar substitute known as xylitol is associated with higher risks of heart attack and stroke. Xvision/Moment/Getty Images A common artificial sweetener known as xylitol is associated with an…
Telehealth has transformed health care access, making it easier for millions of patients to connect with physicians without leaving home.
Leading U.S. medical groups are urging people to get updated flu and COVID-19 vaccinations this fall, banding together Wednesday to issue shot guidelines — and highlight the science behind them…
Hong Kong authorities have arrested a 28-year-old man in charge of a clinic accused of selling a laboratory reagent as a bogus vaccine against more than 20 types of cancer.
